Company intelligence / Profile preview
Theraclone Sciences
Seattle, Washington, United Statestheraclone-sciences.com ↗
- Ownership
- Private
- Employees
- ~32
- Development stage
- Preclinical
01
Overview
Theraclone Sciences specializes in the discovery and development of fully human monoclonal antibody therapeutics using its proprietary I-STARM™ technology. The company has advanced candidates into clinical trials—most notably TCN‑032 for serious influenza showed statistically significant reduction in viral load and improved symptoms in a Phase IIa model. Its HIV broadly neutralizing antibodies have been licensed to Gilead for further development as part of an HIV cure regimen. Other programs target oncology indications through partnerships such as with OncoResponse.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- monoclonal antibodies (mAbs)fully human antibodiesgene delivery technology (lentiviral vector; limited info)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Gilead Sciences (HIV program licensee)PfizerZenyaku KogyoIAVIOncoResponse (platform licensee/partnered oncology pipeline)Wellcome Trust/BIO Ventures for Global Health consortium on Ebola project.
Beyond the preview
Go deeper on Theraclone Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theraclone Sciences.